Can the peony, a plant having a long history of consumption and medicinal value in China, play a role in the treatment of type 2 diabetes mellitus? Researchers using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and high-performance liquid chromatography (HPLC) set out to find the answer.
Researchers affiliated with Henan Napu Biotechnology Company, the Henan Institute of Business Science, the Henan Academy of Sciences, and Henan Agricultural University (all located in Zhengzhou, China) established a type 2 diabetes mellitus (T2DM) mouse model using a high-fat diet (HFD) combined with streptozotocin (STZ) to determine the effects of peony flowers polyphenols (PP) on the fasting blood glucose (FBG), serum insulin, glucose tolerance, serum biochemical indicators, liver oxidation indicators, and intestinal short-chain fatty acids (SCFAs) of those mice. To explore the mechanism of PP in lowering blood glucose, the changes of intestinal flora in mouse cecum contents were analyzed using 16SrRNA sequencing, and serum metabolomics was detected using liquid chromatography-tandem mass spectrometry (LC-MS/MS). A paper based on their work was published in Frontiers in Nutrition (1).
Diabetes mellitus (DM) remains a major public health challenge, posing serious risks to human health following tumors, cardiovascular, and cerebrovascular diseases. Furthermore, both its incidence and mortality rates are rapidly increasing globally (2). The number of patients with diabetes is projected to reach 783 million by 2045, with type 2 diabetes mellitus (T2DM), a complex endocrine, metabolic disease characterized by elevated blood glucose and abnormal blood lipid levels, accounting for nearly 90% of all reported cases (3,4). Failure to manage one’s diabetes may lead to serious long-term complications, including chronic kidney disease, retinopathy, cardiovascular disease, and neuropathy, thereby increasing the mortality rate (5,6).
The peony, often referred to as the “King of Flowers,” boasts abundant resources and has a consumption and medicinal history in China of more than a thousand years. The flower is rich in polyphenols, flavonoids, polysaccharides, and other components, as well as antibacterial, antioxidant, anti-photoaging, anti-aging, α-glucosidase and α-amylase inhibitor activities (7–11). While the researcher’s previous work revealed that peony flowers polyphenols have inhibitory effects on α-glucosidase activity (12), they state that there have been no relevant reports on the hypoglycemic effect and mechanism of action of PP (1).
The researchers extracted and isolated PP from peony flowers (Paeonia ostii “Fengdan”), and its total polyphenol content (TPC) was verified by the Folin-Ciocalteu method and the contents of 17 components in PP were uncovered through analysis involving high-performance liquid chromatography (HPLC). The HFD/STZ combination was then used to establish the T2DM mouse model, and the hypoglycemic effect and mechanism of PP based on gut microbiota and metabolomics were investigated (1).
Analysis revealed that the TPC in PP was 81.13 ± 2.89%, and that, after eight weeks of intragastric administration, PP significantly reduced the fasting blood glucose (FBG), serum insulin level, and insulin resistance index, improved impaired glucose tolerance, and regulated serum liver and kidney function related indicators. In addition, it significantly increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-PX) levels, significantly decreased malondialdehyde (MDA) level in the liver, and increased the contents of short-chain fatty acids (SCFAs) in the gut of T2DM mice. Non-targeted metabolomics results revealed that the high-dose group of PP (PPH) can reverse the metabolic disorders of metabolite markers induced by T2DM in vivo (1).
The researchers state that PP may play a hypoglycemic role by regulating intestinal flora and amino acid metabolism pathway, and that their work establishes a foundation for using PP as a functional food to prevent or alleviate type 2 diabetes mellitus. However, due to the hypoglycemic mechanism of PP involving multiple components and targets, they add that further verification and research through fecal transplantation and other techniques is needed (1).
Pink peony flower. © Olga Miltsova - stock.adobe.com.
References
Navigating the Impact of Funding Cuts: Voices from the Research Community
July 9th 2025Shifts in U.S. federal science funding—driven by the newly established Department of Government Efficiency (DOGE)—are causing delays, uncertainty, and program changes across academic and regulatory research institutions.